{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:22:23Z","timestamp":1774952543161,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001626","name":"Public Health Agency Northern Ireland","doi-asserted-by":"publisher","award":["COM\/4965\/14"],"award-info":[{"award-number":["COM\/4965\/14"]}],"id":[{"id":"10.13039\/501100001626","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.adro.2023.101396","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T04:34:04Z","timestamp":1705811644000},"page":"101396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Validation of a Quality Metric Score to Assess the Placement of Hydrogel Rectal Spacer in Patients Treated With Prostate Stereotactic Radiation Therapy"],"prefix":"10.1016","volume":"9","author":[{"given":"Valentina","family":"Giacometti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8789-4526","authenticated-orcid":false,"given":"Owen","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Comiskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orla A.","family":"Houlihan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Whitten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M.","family":"Prise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan R.","family":"Hounsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suneil","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conor K.","family":"McGarry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2023.101396_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-8-171","article-title":"Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: Preliminary report of a phase II study","volume":"8","author":"Alongi","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101396_bib0002","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2217\/fon.15.14","article-title":"Clinical trials of stereotactic ablative radiotherapy for prostate cancer: Updates and future direction","volume":"11","author":"Musunuru","year":"2015","journal-title":"Futur Oncol"},{"key":"10.1016\/j.adro.2023.101396_bib0003","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijrobp.2018.12.045","article-title":"Five-year outcomes of a phase 1 dose-escalation study using stereotactic body radiosurgery for patients with low-risk and intermediate-risk prostate cancer","volume":"104","author":"Zelefsky","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101396_bib0004","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijrobp.2018.05.040","article-title":"Multicenter trial of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer: Survival and toxicity endpoints","volume":"102","author":"Meier","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101396_bib0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejca.2016.02.014","article-title":"Stereotactic body radiation therapy for low and intermediate risk prostate cancer: Results from a multi-institutional clinical trial","volume":"59","author":"Hannan","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2023.101396_bib0006","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.euo.2018.06.013","article-title":"Phase 2 multicenter trial of heterogeneous-dosing stereotactic body radiotherapy for low- and intermediate-risk prostate cancer: 5-year outcomes","volume":"1","author":"Fuller","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.adro.2023.101396_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2014.00319","article-title":"Stereotactic body radiation therapy for prostate cancer: Review of experience of a multicenter phase I\/II dose-escalation study","volume":"4","author":"Kim","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2023.101396_bib0008","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ijrobp.2014.03.012","article-title":"Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer","volume":"89","author":"Kim","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101396_bib0009","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijrobp.2016.12.024","article-title":"Continued benefit to rectal separation for prostate radiation therapy: Final results of a phase III trial","volume":"97","author":"Hamstra","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101396_bib0010","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ijrobp.2014.11.027","article-title":"Prostate hypofractionated radiation therapy with injection of hyaluronic acid: Acute toxicities in a phase 2 study","volume":"91","author":"Chapet","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101396_bib0011","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijrobp.2014.06.044","article-title":"Optimization of radiation therapy techniques for prostate cancer with prostate-rectum spacers: A systematic review","volume":"90","author":"Mok","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101396_bib0012","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijrobp.2012.12.019","article-title":"A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: Analysis of dosimetric outcomes","volume":"87","author":"Song","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101396_bib0013","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijrobp.2021.03.025","article-title":"A multi-institutional phase 2 trial of high-dose SAbR for prostate cancer using rectal spacer","volume":"111","author":"Folkert","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101396_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1259\/bjr.20170672","article-title":"Efficacy of a rectal spacer with prostate SABR\u2014first UK experience","volume":"91","author":"King","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1016\/j.adro.2023.101396_bib0015","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/j.urology.2021.05.013","article-title":"SpaceOAR hydrogel spacer for reducing radiation toxicity during radiotherapy for prostate cancer. A systematic review","volume":"156","author":"Armstrong","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.adro.2023.101396_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-019-1248-6","article-title":"Rectum-spacer related acute toxicity: Endoscopy results of 403 prostate cancer patients after implantation of gel or balloon spacers","volume":"14","author":"Sch\u00f6rghofer","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101396_bib0017","first-page":"1","article-title":"Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer","volume":"27","author":"Eckert","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.adro.2023.101396_bib0018","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.prro.2016.10.004","article-title":"Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall","volume":"7","author":"Fischer-Valuck","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101396_bib0019","first-page":"1","article-title":"Quality metric to assess adequacy of hydrogel rectal spacer placement for prostate radiation therapy and association of metric score with rectal toxicity outcomes","volume":"8","author":"Grossman","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101396_bib0020","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijrobp.2023.02.054","article-title":"A randomized feasibility trial of stereotactic prostate radiation therapy with or without elective nodal irradiation in high-risk localized prostate cancer (sPORT trial)","volume":"117","author":"Houlihan","year":"2023","journal-title":"Int Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101396_bib0021","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/1754-9485.12152","article-title":"Feasibility of and rectal dosimetry improvement with the use of SpaceOAR hydrogel for dose-escalated prostate cancer radiotherapy","volume":"58","author":"Van Gysen","year":"2014","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101396_bib0022","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejmp.2007.07.001","article-title":"A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy","volume":"23","author":"Gay","year":"2007","journal-title":"Phys Medica"},{"key":"10.1016\/j.adro.2023.101396_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamanetworkopen.2020.8221","article-title":"Association of the placement of a perirectal hydrogel spacer with the clinical outcomes of men receiving radiotherapy for prostate cancer: A systematic review and meta-analysis","volume":"3","author":"Miller","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.adro.2023.101396_bib0024","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/bju.15097","article-title":"Long-term follow-up after radiotherapy for prostate cancer with and without rectal hydrogel spacer: A pooled prospective evaluation of bowel-associated quality of life","volume":"126","author":"Seymour","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.adro.2023.101396_bib0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/S1460396919000979","article-title":"What is the quality of hydrogel spacer insertions? And which patients will benefit? A literature review","volume":"19","author":"Drabble","year":"2020","journal-title":"J Radiother Pract"},{"key":"10.1016\/j.adro.2023.101396_bib0026","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.ijrobp.2009.07.1679","article-title":"Effects of prostate-rectum separation on rectal dose from external beam radiotherapy","volume":"76","author":"Susil","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101396_bib0027","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.radonc.2011.09.005","article-title":"Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer","volume":"100","author":"Pinkawa","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101396_bib0028","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","article-title":"Hydrogel spacer prospective multicenter randomized controlled pivotal trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy","volume":"92","author":"Mariados","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101396_bib0029","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/j.clon.2016.05.005","article-title":"SpaceOAR hydrogel in dose-escalated prostate cancer radiotherapy: Rectal dosimetry and late toxicity","volume":"28","author":"Whalley","year":"2016","journal-title":"Clin Oncol"},{"key":"10.1016\/j.adro.2023.101396_bib0030","unstructured":"National Institute for Health and Care Excellence. Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer. Accessed May 15, 2022. https:\/\/www.nice.org.uk\/guidance\/ipg590\/resources\/biodegradable-spacer-insertion-to-reduce-rectal-toxicity-during-radiotherapy-for-prostate-cancer-pdf-1899872222405317"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109423002245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109423002245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:45:47Z","timestamp":1762530347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109423002245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2452109423002245"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2023.101396","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of a Quality Metric Score to Assess the Placement of Hydrogel Rectal Spacer in Patients Treated With Prostate Stereotactic Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2023.101396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101396"}}